Drug recall · September 24, 2014
Candesartan Cilexetil and Hydrochlorothiazide Tablets 32 mg/12.5 mg recall
Why: Failed Impurity/Degradation Specification; high out of specification for CAD II degradant
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Candesartan Cilexetil and Hydrochlorothiazide Tablets 32 mg/12.5 mg, 90 count bottles, Rx only, Manufactured by: Apotex Research Pvt. Ltd. Bangalore - 560 099, India NDC 60505-3759-9
- Lots / codes
Lot # KK6086, exp 03/2015, UPC 360505375998.
- Quantity
- 1,494 bottles
- Company
- Apotex Corp., Weston, FL
- Distribution
- Nationwide
- Initiated
- August 21, 2014 · Voluntary: Firm initiated
- Classified
- September 15, 2014
- Reported
- September 24, 2014
- Ended
- October 2, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Hydrochlorothiazide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.